Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-28 08:37 am Purchase |
2023-12-31 | 13G | Nuvectis Pharma, Inc. NVCT |
Mosseri Marlio Charles | 2,595,000 15.000% |
214,824 (+9.03%) |
Filing History |
| 2024-02-14 4:06 pm Purchase |
2023-12-31 | 13G | Beyond Air, Inc. XAIR |
Mosseri Marlio Charles | 3,330,250 9.210% |
311,543 (+10.32%) |
Filing History |
| 2023-02-14 4:10 pm Purchase |
2022-12-31 | 13G | Beyond Air, Inc. XAIR |
Mosseri Marlio Charles | 3,018,707 9.990% |
706,080 (+30.53%) |
Filing History |
| 2023-01-09 10:19 am Purchase |
2022-12-30 | 13G | Nuvectis Pharma, Inc. NVCT |
Mosseri Marlio Charles | 2,380,176 16.300% |
977,620 (+69.70%) |
Filing History |
| 2022-03-28 6:46 pm Purchase |
2022-03-22 | 13G | Nuvectis Pharma, Inc. NVCT |
Mosseri Marlio Charles | 1,402,556 11.030% |
1,402,556 (New Position) |
Filing History |
| 2022-02-15 5:18 pm Purchase |
2022-02-08 | 13G | Nuvectis Pharma, Inc. NVCT |
Mosseri Marlio Charles | 1,265,200 9.950% |
1,265,200 (New Position) |
Filing |
| 2022-02-08 5:35 pm Purchase |
2021-12-31 | 13G | Beyond Air, Inc. XAIR |
Mosseri Marlio Charles | 2,312,627 7.760% |
333,062 (+16.83%) |
Filing History |
| 2021-05-04 4:38 pm Purchase |
2021-04-30 | 13G | Beyond Air, Inc. XAIR |
Mosseri Marlio Charles | 1,979,565 9.600% |
564,169 (+39.86%) |
Filing History |